Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Schizophrenia

Free Subscription Articles published in J Clin Psychopharmacol Retrieve available abstracts of 66 articles: HTML format Text format

Single Articles

February 2010
1. BATALLA A , Vera M, Torra M, Parellada E, et al
   Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.
   J Clin Psychopharmacol. 2010;30:92-4.
   PubMed     Text format     Related articles   
   
   
   
2. CASSIDY CM , Rabinovitch M, Schmitz N, Joober R, et al
   A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis.
   J Clin Psychopharmacol. 2010;30:64-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
3. WEINBERGER AH , Hitsman B, Papandonatos GD, Sacco KA, et al
   Predictors of abstinence and changes in psychiatric symptoms in a pooled sample of smokers with schizophrenia receiving combination pharmacotherapy and behavioral therapy for smoking cessation.
   J Clin Psychopharmacol. 2009;29:601-3.
   PubMed     Text format     Related articles   
   
   
   
4. UCHIDA H , Rajji TK, Mulsant BH, Kapur S, et al
   D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia.
   J Clin Psychopharmacol. 2009;29:571-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GLICK ID , Bossie CA, Alphs L, Canuso CM, et al
   Onset and persistence of antipsychotic response in patients with schizophrenia.
   J Clin Psychopharmacol. 2009;29:542-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
6. KAWAI N , Ishikawa K, Nemoto K, Katano T, et al
   Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia.
   J Clin Psychopharmacol. 2009;29:499-501.
   PubMed     Text format     Related articles   
   
   
   
7. HOUGH D , Nuamah IF, Lim P, Sampson A, et al
   Independent effect of paliperidone extended release on social functioning beyond its effect on positive and negative symptoms of schizophrenia: a mediation analysis.
   J Clin Psychopharmacol. 2009;29:496-7.
   PubMed     Text format     Related articles   
   
   
   August 2009
8. GRUNZE HC , Hoschl C, Montgomery SA, Sartorius N, et al
   Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).
   J Clin Psychopharmacol. 2009;29:409.
   PubMed     Text format     Related articles   
   
   
   
9. TAKEUCHI H , Uchida H, Suzuki T, Watanabe K, et al
   Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study.
   J Clin Psychopharmacol. 2009;29:394-5.
   PubMed     Text format     Related articles   
   
   
   
10. CHANG YC , Lane HY
    Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
    J Clin Psychopharmacol. 2009;29:391.
    PubMed     Text format     Related articles   
    
    
    
11. GHIO L , Fornaro G, Rossi P
    Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    J Clin Psychopharmacol. 2009;29:391-2.
    PubMed     Text format     Related articles   
    
    
    June 2009
12. CHEN L , Kollack-Walker S, Lipkovich IA
    Comments on "Optimizing early prediction for antipsychotic response in schizophrenia" by Chang et al.
    J Clin Psychopharmacol. 2009;29:311-2.
    PubMed     Text format     Related articles   
    
    
    
13. SENTISSI O , Grouselle D, Viala A, Bourdel MC, et al
    Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy.
    J Clin Psychopharmacol. 2009;29:304-6.
    PubMed     Text format     Related articles   
    
    
    
14. LAAN W , Smeets H, de Wit NJ, Kahn RS, et al
    Glucocorticosteroids associated with a decreased risk of psychosis.
    J Clin Psychopharmacol. 2009;29:288-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. CITROME L , Stauffer VL, Chen L, Kinon BJ, et al
    Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.
    J Clin Psychopharmacol. 2009;29:278-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. KANG RH , Jung SM, Kim KA, Lee DK, et al
    Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.
    J Clin Psychopharmacol. 2009;29:272-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. GLICK ID , Bosch J, Casey DE
    A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
    J Clin Psychopharmacol. 2009;29:267-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SCHWARCZ G , Karajgi B, McCarthy R
    Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.
    J Clin Psychopharmacol. 2009;29:255-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. STERN RG , Petti TA, Bopp K, Tobia A, et al
    Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.
    J Clin Psychopharmacol. 2009;29:206-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. MANTEGHI A , Hojjat SK, Javanbakht A
    Remission of tardive dystonia with electroconvulsive therapy.
    J Clin Psychopharmacol. 2009;29:314-5.
    PubMed     Text format     Related articles   
    
    
    
21. SPARVE E , Nordberg P, Forsberg S, Hellden A, et al
    Acute clozapine intoxication.
    J Clin Psychopharmacol. 2009;29:302-4.
    PubMed     Text format     Related articles   
    
    
    
22. JIN H , Lanouette NM, Mudaliar S, Henry R, et al
    Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome.
    J Clin Psychopharmacol. 2009;29:210-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
23. HOWES OD , Hundal H
    Sex hormone augmentation as an adjunctive treatment in schizophrenia.
    J Clin Psychopharmacol. 2009;29:195-6.
    PubMed     Text format     Related articles   
    
    
    
24. PAE CU
    Comments on "Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial" by Dr Ko and colleagues.
    J Clin Psychopharmacol. 2009;29:194-5.
    PubMed     Text format     Related articles   
    
    
    
25. SALMASI FB , Jazayeri M, Ghaeli P, Hashemian F, et al
    Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine.
    J Clin Psychopharmacol. 2009;29:182-3.
    PubMed     Text format     Related articles   
    
    
    
26. HENDERSON DC , Fan X, Copeland PM, Sharma B, et al
    Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.
    J Clin Psychopharmacol. 2009;29:165-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. STEFANOVIC A , Brandner B, Klaassen E, Cregg R, et al
    Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?
    J Clin Psychopharmacol. 2009;29:124-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. AHN YM , Lee KY, Kim CE, Kim JJ, et al
    Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.
    J Clin Psychopharmacol. 2009;29:117-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. ANGELINI MC , MacCormack-Gagnon J, Dizio S
    Increase in plasma levels of clozapine after addition of isoniazid.
    J Clin Psychopharmacol. 2009;29:190-1.
    PubMed     Text format     Related articles   
    
    
    
30. PRAHARAJ SK , Sarkar S, Sinha VK
    Amisulpride treatment for clozapine-induced sialorrhea.
    J Clin Psychopharmacol. 2009;29:189-90.
    PubMed     Text format     Related articles   
    
    
    
31. KAHN D , Leung M, Kalivas K, Quanbeck C, et al
    Two patients with recurring syndrome of inappropriate secretion of antidiuretic hormone on multiple atypical antipsychotics.
    J Clin Psychopharmacol. 2009;29:186-9.
    PubMed     Text format     Related articles   
    
    
    
32. PAPAZISIS G , Tzellos T, Tahmatzidis D, Dolianitis K, et al
    Late-onset clozapine-induced hypothermia accompanied by electrocardiogram Osborn waves.
    J Clin Psychopharmacol. 2009;29:183-5.
    PubMed     Text format     Related articles   
    
    
    
33. OZBILEN M , Adams CE
    Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs.
    J Clin Psychopharmacol. 2009;29:141-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
34. MULDER H , Cohen D, Scheffer H, Gispen-de Wied C, et al
    HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study.
    J Clin Psychopharmacol. 2009;29:16-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. CHONG SA , Tay JA, Subramaniam M, Pek E, et al
    Mortality rates among patients with schizophrenia and tardive dyskinesia.
    J Clin Psychopharmacol. 2009;29:5-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. JONG-YIH L
    Successful switch from clozapine to aripiprazole: a case report.
    J Clin Psychopharmacol. 2009;29:93-5.
    PubMed     Text format     Related articles   
    
    
    
37. KONSTANTAKOPOULOS G , Oulis P, Michalopoulou PG, Papadimitriou GN, et al
    Olanzapine-induced "restless arms syndrome".
    J Clin Psychopharmacol. 2009;29:89-90.
    PubMed     Text format     Related articles   
    
    
    
38. GUNES A , Melkersson KI, Scordo MG, Dahl ML, et al
    Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    J Clin Psychopharmacol. 2009;29:65-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. GREGOOR JG , van der Weide J, Mulder H, Cohen D, et al
    Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
    J Clin Psychopharmacol. 2009;29:21-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
40. BAI YM , Chen TT, Lin WK, Chang WH, et al
    Reply to Comments by Dr Peng et al for "Pharmacokinetics Study for Hyperprolactinemia Among Schizophrenics Switched from Risperidone to Risperidone Long-Acting Injection"
    J Clin Psychopharmacol. 2008;28:727-728.
    PubMed     Text format     Related articles   
    
    
    
41. PARK YM , Lee SH, Lee HJ, Kim H, et al
    Ziprasidone-associated mania in Korean schizophrenic patient.
    J Clin Psychopharmacol. 2008;28:711-3.
    PubMed     Text format     Related articles   
    
    
    
42. BAR KJ , Koschke M, Berger S, Schulz S, et al
    Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia.
    J Clin Psychopharmacol. 2008;28:694-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. SHEN J , Kobak KA, Zhao Y, Alexander MM, et al
    Use of remote centralized raters via live 2-way video in a multicenter clinical trial for schizophrenia.
    J Clin Psychopharmacol. 2008;28:691-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. KINON BJ , Stauffer VL, Kollack-Walker S, Chen L, et al
    Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    J Clin Psychopharmacol. 2008;28:601-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. PENG PW , Huang MC, Tsai CJ, Pan CH, et al
    The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
    J Clin Psychopharmacol. 2008;28:726-7.
    PubMed     Text format     Related articles   
    
    
    
46. UZUN S , Kozumplik O, Jakovljevic M, Folnegovic-Smalc V, et al
    Leukopenia during therapy with risperidone long-acting injectable: two case reports.
    J Clin Psychopharmacol. 2008;28:713-4.
    PubMed     Text format     Related articles   
    
    
    
47. PELIZZA L
    Long-acting risperidone-induced periorbital edema.
    J Clin Psychopharmacol. 2008;28:709-10.
    PubMed     Text format     Related articles   
    
    
    
48. LEE E , Leung CM
    Atypical antipsychotics and metabolic outcomes in Chinese patients: a comparison of olanzapine and risperidone.
    J Clin Psychopharmacol. 2008;28:707-9.
    PubMed     Text format     Related articles   
    
    
    
49. CHARBONNEAU K , Landry P
    Leukopenia and neutropenia after intoxication with diphenhydramine (Nytol) during clozapine treatment.
    J Clin Psychopharmacol. 2008;28:706-7.
    PubMed     Text format     Related articles   
    
    
    
50. VEHOF J , Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, et al
    Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    J Clin Psychopharmacol. 2008;28:625-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. VERNALEKEN I , Fellows C, Janouschek H, Brocheler A, et al
    Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    J Clin Psychopharmacol. 2008;28:608-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
52. KOUVELOU E , Pourzitaki C, Aroni F, Papazisis G, et al
    Acute psychosis induced by clarithromycin in a healthy adult?
    J Clin Psychopharmacol. 2008;28:579-80.
    PubMed     Text format     Related articles   
    
    
    
53. MONTEJO AL , Rico-Villademoros F
    Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    J Clin Psychopharmacol. 2008;28:568-70.
    PubMed     Text format     Related articles   
    
    
    
54. KINON BJ , Ascher-Svanum H, Adams DH, Chen L, et al
    The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.
    J Clin Psychopharmacol. 2008;28:544-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. TAKEUCHI H , Suzuki T, Uchida H, Nakajima S, et al
    A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.
    J Clin Psychopharmacol. 2008;28:540-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. LEE J , Poon LY, Chong SA
    Spontaneous dyskinesia in first-episode psychosis in a Southeast Asian population.
    J Clin Psychopharmacol. 2008;28:536-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. KRAKOWSKI MI , Czobor P, Nolan KA
    Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    J Clin Psychopharmacol. 2008;28:485-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. YOON CK
    Weight gain and first-generation antipsychotics: experience from a developing country.
    J Clin Psychopharmacol. 2008;28:574-6.
    PubMed     Text format     Related articles   
    
    
    
59. SEVINCOK L , Balci V, Akyildiz U
    Tardive dystonia associated with low-dose of amisulpride: a case report.
    J Clin Psychopharmacol. 2008;28:573-4.
    PubMed     Text format     Related articles   
    
    
    
60. MALL GD , Hake L, Benjamin AB, Adityanjee A, et al
    Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    J Clin Psychopharmacol. 2008;28:572-3.
    PubMed     Text format     Related articles   
    
    
    
61. SCHLACHETZKI JC , Langosch JM
    Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?
    J Clin Psychopharmacol. 2008;28:567-8.
    PubMed     Text format     Related articles   
    
    
    August 2008
62. DAUNER DG , Deremer CE, Haburchak D
    Clozapine-induced pericardial effusion.
    J Clin Psychopharmacol. 2008;28:455-6.
    PubMed     Text format     Related articles   
    
    
    
63. FINDLING RL , Kauffman RE, Sallee FR, Carson WH, et al
    Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
    J Clin Psychopharmacol. 2008;28:441-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
64. SHIM JC , You YS, Kelly DL
    Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
    J Clin Psychopharmacol. 2008;28:353-4.
    PubMed     Text format     Related articles   
    
    
    
65. LANDRY P , Dimitri E, Tessier S, Legare N, et al
    Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    J Clin Psychopharmacol. 2008;28:348-9.
    PubMed     Text format     Related articles   
    
    
    
66. PEREZ-IGLESIAS R , Vazquez-Barquero JL, Amado JA, Berja A, et al
    Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment.
    J Clin Psychopharmacol. 2008;28:289-95.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: